Burlington, MA, United States of America

Werner Meier

USPTO Granted Patents = 11 (Patent Applications = 4)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 5 (Patent Applications = 7)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 82(Granted Patents)

Company Filing History:

1 out of 832,680

Other

patents

Years Active: 2001-2023

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11702482 - Twin immune cell engager (2023-07-18),

2. 9228015 - Nogo receptor antagonists and methods of increasing neurite outgrowth (2016-01-05),

3. 8709759 - Method for increasing expression of active tumor necrosis factor receptor family member-Ig fusion proteins (2014-04-29),

4. 8669345 - Nogo receptor antagonists (2014-03-11),

5. 8618252 - Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto (2013-12-31),

6. 8338376 - Compositions comprising variant LT-B-R-IG fusion proteins (2012-12-25),

7. 8283138 - Method for the high level expression of active tumor necrosis receptor family member immunoglobulin fusion proteins (2012-10-09),

8. 7585946 - Active lymphotoxin-β receptor immunoglobulin chimeric protein compositions (2009-09-08),

9. 7459537 - Anti-lymphotoxin-β receptor antibodies as anti-tumor agents (2008-12-02),

10. 7001598 - Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents (2006-02-21),

11. 6312691 - Lymphotoxin-&agr;/&bgr; complexes and anti-lympotoxin-&bgr; receptor antibodies as anti-tumor agents (2001-11-06),

Title: Werner Meier: Innovator in Cancer Treatment and Neurite Outgrowth

Introduction

Werner Meier is a prominent inventor based in Burlington, MA (US), known for his significant contributions to the fields of cancer treatment and neurobiology. With a total of 11 patents to his name, Meier has developed innovative solutions that address critical medical challenges.

Latest Patents

One of his latest inventions is the Twin Immune Cell Engager (TWICE), which is a kit designed for treating cancer. This composition includes two components, each containing a targeting moiety that binds to tumor antigens expressed by cancer cells or antigens found in the tumor microenvironment. The components are engineered to enhance immune cell binding activity, thereby improving the efficacy of cancer treatment. Another notable patent involves Nogo receptor antagonists and methods for increasing neurite outgrowth. This invention includes immunogenic Nogo receptor-1 polypeptides, antibodies, and compositions that facilitate nerve regeneration, showcasing Meier's versatility in addressing both oncology and neurobiology.

Career Highlights

Throughout his career, Werner Meier has worked with notable companies, including Biogen Idec Massachusetts Inc. His work has significantly impacted the development of therapies aimed at treating complex diseases, particularly in the realms of cancer and nerve regeneration.

Collaborations

Meier has collaborated with esteemed colleagues such as Jeffrey L. Browning and Christopher D. Benjamin, contributing to a rich exchange of ideas and innovations in his field.

Conclusion

Werner Meier's innovative spirit and dedication to advancing medical science are evident in his numerous patents and collaborations. His work continues to pave the way for new treatments that can improve patient outcomes in cancer and neurobiology.

This text is generated by artificial intelligence and may not be accurate.